Compare INVH & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVH | TIVC |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 3.6M |
| IPO Year | 2017 | 2021 |
| Metric | INVH | TIVC |
|---|---|---|
| Price | $26.79 | $2.09 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $35.22 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 89.4K |
| Earning Date | 10-29-2025 | 11-14-2025 |
| Dividend Yield | ★ 4.40% | N/A |
| EPS Growth | ★ 32.35 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $2,689,621,000.00 | $482,000.00 |
| Revenue This Year | $5.69 | N/A |
| Revenue Next Year | $3.21 | N/A |
| P/E Ratio | $27.74 | ★ N/A |
| Revenue Growth | ★ 5.29 | N/A |
| 52 Week Low | $26.02 | $1.47 |
| 52 Week High | $35.80 | $15.64 |
| Indicator | INVH | TIVC |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 46.23 |
| Support Level | $26.19 | $1.72 |
| Resistance Level | $26.85 | $2.70 |
| Average True Range (ATR) | 0.47 | 0.19 |
| MACD | -0.09 | 0.07 |
| Stochastic Oscillator | 30.25 | 29.89 |
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.